| Literature DB >> 31477792 |
Jayaweera Arachchige Asela Sampath Jayaweera1, Mohammed Reyes2, Anpalaham Joseph3.
Abstract
Anemia affects approximately 30% of children all over the world. Acute respiratory tract infections (ARTI), urinary tract infections (UTI) and gastroenteritis (GE) are common infectious entities in children. Here, we assessed the association between anemia and development of recurrent ARTI, UTI, and GE in children. This was a case-control study in hospitalized 2-5 years old children in Professorial Pediatric Unit at Teaching Hospital Anuradhapura, Sri Lanka. An 18-month follow up was done to assess the risk factors for the development of recurrent ARTI, GE, UTI, and control presented without infections. Further, 6-month follow up done after 3-month iron supplementation to assess the occurrence of recurrences. Blood Hb concentration was measured using Drabking's reagent. Logistic regression was used to find the risk factors for the development of recurrences. In ARTI, 121/165 (73.3%), GE, 88/124 (71%), UTI 46/96 (47.9%) and control 40/100 (40%) were having anemia. Initial ARTI group, recurrent ARTI was 24 (14.5%, p = 0.03); initial GE group: recurrent GE was 14 (11.3%, p = 0.03), recurrent ARTI was 11 (8.9%, p = 0.04); initial UTI group, development of; recurrent UTI was 8 (8.3%, p = 0.04); control, recurrent ARTI was 11 (11%, p = 0.03). Following 3-month iron supplementation reduction of recurrences was significant: initial ARTI recurrent ARTI in 90%, recurrent GE in 77.7%; initial GE recurrent GE in 83.3%, recurrent ARTI in 80%; initial UTI recurrent ARTI in 71.4% and control recurrent ARTI in 88.8%. Iron deficiency is a major type of anemia and anemic children are more prone to develop recurrent ARTI and GE. Once iron deficiency being corrected the rate of recurrent ARTI and GE was reduced. This would be a boost for policy developers to implement strategies at the community level to prevent iron deficiency in children to reduce ARTI and GE recurrences.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31477792 PMCID: PMC6718651 DOI: 10.1038/s41598-019-49122-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Details of recurrent infections before, after 3 month of iron supplementation and 6 months follow up.
| Initial group (n) | ARTI (165) | GE (124) | UTI (96) | Control (100) | P value and comments | ||
|---|---|---|---|---|---|---|---|
| Percentage of Iron deficiency anemia (%) |
|
|
|
|
| ||
| Recurrent infections among anemics (%) |
|
|
|
|
|
| — |
| Recurrent infections among anemics (%) |
|
|
|
|
|
| — |
| Initial Hb (g/dl) | 9.6 ± 0.8 | 9.5 ± 0.7 | 9.7 ± 0.8 | 9.6 ± 0.9 | — | ||
| Initial serum ferritin (ng/ml) | 4.5 ± 1.2 | 4.5 ± 1.1 | 4.5 ± 1.2 | 5.5 ± 0.3 | — | ||
|
| |||||||
| Initial group |
|
|
|
| |||
| At 3-month Hb (g/dl) | 11.3 ± 0.2* | 11.6 ± 0.4* | 11.4 ± 0.3* | 11.9 ± 0.3* | 0.03* | ||
| serum ferritin (ng/ml) | 12.6 ± 0.8** | 12.6 ± 0.4** | 12.6 ± 0.8** | 12.2 ± 0.7** | 0.02** | ||
|
| |||||||
| Recurrent infection |
|
|
|
|
|
| — |
| At 6-month Hb (g/dl) | 11.6 ± 0.4 | 12.1 ± 0.6 | 12.4 ± 0.3 | 11.9 ± 0.2 | — | ||
| Reduction of recurrences over 6 month (%) |
90 |
77.7 |
83.3 |
80 |
71.4 |
88.8 | 0.03 |
ARTI- acute respiratory tract infections, GE- gastro-enteritis, UTI- Urinary tract infections. P < 0.05 taken as significant. -: not significant.
Factors associated with development of recurrent acute respiratory tract infection (ARTI), gastroenteritis (GE) and urinary tract infection (UTI) among followed up ARTI, GE, UTI and control groups.
| Initial disease | ARTI | GE | UTI | Control | P value and comments | |
|---|---|---|---|---|---|---|
| Significant recurrent infection in above disease groups | ARTI | GE | ARTI | UTI | ARTI | |
|
| ||||||
| Sex | ||||||
| Male | 1.6 (1. 5–1.8) | — | — | — | 0.03 | |
| Female | — | — | 1.6 (1.4–1.8) | — | 0.04 | |
Height for age (<−2 SD) | 2.6 (2.1–3.1®) | 1.6 (1.4–1.8)* | 1.6 (1.4–1.8)µ | — | 1.6 (1.4–1.8) | 0.03®, 0.04*, 0.04µ, 0.04 |
| Hb (<11 g/dL) | 5.2 (4.5–5.9)® | 3.6 (3.1–4.1)* | 4.5 (4.0–4.9)µ | — | 4.2 (3.4–4.9) | 0.03®, 0.04*, 0.04µ, 0.04 |
| Constipation | — | — | — | 2.6 (2.2–3.0) | — | 0.04 |
| Water intake <1l | — | — | — | 1.7 (1.4–2.0) | — | 0.04 |
| Hand washing prior to handling of child | — | 1.5 (1.3–1.7)µ | 1.8 (1.3–2.2) | — | — | 0.03µ, 0.04 |
| National program of immunization coverage | 100% | 100% | 100% | 100% | 100% | — |
| Anti-helminth use-every 6 months | 86% | 88% | 84% | 90% | 88% | — |
ARTI- acute respiratory tract infections, GE- gastro-enteritis, UTI- Urinary tract infections, LSCS- lower segmental caesarian section, OR- odds ratio, SD- standard deviation. Only significant factors were included. P < 0.05 taken as significant. -: not significant.
Etiology of recurrent infections before, after 3 month of iron supplementation and 6 months follow up.
| Initial group anemics (n) | ARTI (121) | GE (86) | UTI (44) | Control (35) | ||
|---|---|---|---|---|---|---|
| Etiology | Viral etiology -52 (43%) RSV- 31 (26%), PIV1-3 (2.5%), PIV 2–3 (2.5%), AV-2 (1.6%), hMPV-4 (3.3%), Influenza A- 6 (5%), Influenza B- 3 (2.5%), No etiology 69 (57%) | Etiology detected -56 (65%) RV-32 (37%), AV(g)- 12 (14%), No etiology -30 (35%) | Bacterial etiology -36 (82%) No etiology -8 (18%) | — | ||
| Significant recurrent infections among anemics | ARTI 20 (16.5%) | GE 9 (7.4%) | GE 12 (10%) | ARTI 10 (12%) | ARTI 7 (16%) | ARTI 9 (25%) |
| Etiology | RSV- 18 (90%), Influenza A- 2 (10%) | RV-8 (89%), AV- 1 (11%) | RV-10 (83%), AV- 2 (17%) | RSV-10 (100%) | RSV-7 (100%) | RSV-8 (89%) AV-1 (11%) |
|
| ||||||
| ARTI | GE | UTI | Control | |||
| Recurrent infection at 6 months follow up | ARTI 2 | GE 2 | GE 2 | ARTI 2 | ARTI 2 | ARTI 1 |
| Etiology | RSV-2 (100%) | RV-2 (100%) | RV-2 (100%) | RSV-2 (100%) | RSV-2 (100%) | RSV-1 (100%) |
ARTI- acute respiratory tract infections, UTI- urinary tract infection, GE-gastro-enteritis, RSV-Respiratory syncytial virus, AV- Adenovirus, %), PIV1-parainfluenza virus-1, PIV 2- parainfluenza virus-2, hMPV-human Metapneumovirus, AV(g)- adenovirus causing gastro-enteritis.